{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011278","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2022-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.829316+00:00","generated_at":"2026-06-25T03:53:37.374710+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Arcadia Biosciences CEO Jacot appointed to board; shareholders re-elect directors, ratify auditor, approve executive pay","bullets":["CEO Stanley E. Jacot, Jr. appointed as Class III director to fill vacancy from Matthew Plavan's Dec 2021 resignation.","Annual meeting held June 1, 2022 with 54.40% of outstanding shares present.","Albert Bolles and Kevin Comcowich elected as Class I directors with 5.5M and 6.1M votes for respectively.","Deloitte & Touche LLP ratified as auditor for FY2022 with 11.9M votes for, 90k against.","Say-on-pay advisory vote approved with 5.3M for, 1.3M against, 109k abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011278","json":"https://secwatch.observer/filing/0000950170-22-011278.json","markdown":"https://secwatch.observer/filing/0000950170-22-011278.md","text":"https://secwatch.observer/filing/0000950170-22-011278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022011278/0000950170-22-011278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022011278/rkda-20220601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:53:37.374710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bcd316b006","claim":"Stanley E. Jacot, Jr. was appointed as Class III Director at Arcadia Biosciences, Inc..","evidence_excerpt":"On June 2, 2022, Arcadia’s board of directors appointed Stanley E. Jacot, Jr., Arcadia’s current president and chief executive officer, to serve as a Class III director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022011278/0000950170-22-011278-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}